Please login to the form below

Not currently logged in

Award for Patient-Centricity

Sponsored by

Back to Results


Community Mental Health Project

by Attigo CIC, with support from Johnson and Johnson, The Department for International Development and Yale University

Summary of work

Attigo CIC supported by Johnson and Johnson, The Department for International Development and Yale University have developed a first of its kind community mental health treatment model for people living with schizophrenia and delusional disorders in Accra, Ghana. In line with international best practice the Mental Health Authority in Ghana wants to reduce patients’ dependence on inpatient facilities to limit their mental health beds, with the vast majority of care delivered by community resource, ending restrictive practices in rundown facilities and treating patients in their own homes with their families supporting them. Attigo CiC worked extensively with patients, their families and carers to fully understand their needs and concerns, running multiple workshops throughout the country in advance of scoping the solution. We also worked with psychiatrists, nurses and the Ghanaian Mental Health Authority to develop the entire programme. The result is a comprehensive, evidenced-based care model using remote hand-held digital technology to deliver all aspects of the programme from training though care delivery and outcome measurement. The model leapfrogs western technological models with an agile, portable but all-encompassing model of care in the hands of the clinicians wherever they are, from urban to extreme remote areas.

Judges' comments

The judges thought the Community Mental Health Project was a superb programme. The passion from J&J, The Department for International Development, Yale University and Attigo shone through. It is an important mental health programme, with impressive use of local partners and ambitious objectives. Beautifully collaborative and insightful with truly impressive healthcare outcomes.

Highly commended

NINLARO Patient Support Programme - by Takeda UK and Ireland with support from Apodi Limited


The APPEAL Study: Uncovering Psychosocial Burden in Peanut Allergy - by Aimmune Therapeutics with support from Solaris Health, Acaster Lloyd Consulting and Brainsell

RAREfest - by Cambridge Rare Disease Network with support from Havas Life Medicom

GLAD I Took Part - by King’s College London with support from Four Health

Key dates

Entry deadline 26 August 2022
Extended entry deadline 2 September 2022*
*additional fee applies
Judging Day 6 October 2022
Company/Team of the Year Interviews 21 October 2022
PMEA Event 23 November 2022